Investopedia: Does The Market Expect Trouble At Accenture?

Sometimes, investors should step back and compare the conventional wisdom on a story with what actually seems to be in the price. Accenture (NYSE:ACN) has long been called a Wall Street "darling" as it is arguably the most well-respected name in global consulting and outsourcing. Yet, despite this love and despite the ongoing growth in its core markets, Accenture's current share price does not seem overvalued at all.

A Surprising Cap to the Year  
Accenture ended the year on a strong note. Reported revenue rose 23%, or 14% in local currency, from last year's level and stayed flat on a sequential basis. Growth was pretty consistent across all of the categories - consulting was up 25% annually and down 2% sequentially, while outsourcing was up 21% annually and up 2% sequentially. Across the major market categories, growth was generally in the 20%+ range (except for the health/public service category), though financial services was a little soft on a sequential basis.

To read more, click the link:
http://stocks.investopedia.com/stock-analysis/2011/Does-The-Market-Expect-Trouble-At-Accenture-ACN-IBM-INFY-CSC-HPQ-DELL-CTSH1002.aspx

Invesotpedia: Can CACI Get A Bigger Piece Of A Smaller Pie?

Weak federal government spending has been a problem for a lot of companies recently, including Cisco (Nasdaq:CSCO) and NetApp (Nasdaq:NTAP). With major worries about the unsustainability of recent budget deficits and political pressure to cut spending, it wouldn't seem like a good time to invest in companies that largely rely on federal business for their revenue. Still, with IT products and services that help government agencies modernize and cut costs, CACI International (NYSE:CACI) may be able to capture a bigger piece of smaller budgets. (To help further identify company success, read 3 Secrets Of Successful Companies.)

A Stronger Fourth Quarter Than Expected  
CACI managed to log better than 13% growth in the fiscal fourth quarter, slightly beating the average analyst guess. Organic growth was strong as well, at better than 11%. As usual, business from the Department of Defense was the driver this quarter - up more than 17% and making up 81% of sales. Revenue from federal civilian agencies, the company's second largest category, was down more than 2%.

To continue to the full piece, click the link below:
http://stocks.investopedia.com/stock-analysis/2011/Can-CACI-Get-A-Bigger-Piece-Of-A-Smaller-Pie-CACI-CSC-SAI-IBM-LMT-RTN-LLL0820.aspx

Investopedia: Signings A Small Thorn In IBM's Paw

Old-tech hasn't been getting much love lately, but this earnings cycle may help bring investors back to many of these old-school tech names. For although weak signings in the service business may send some investors to the sidelines, IBM (NYSE:IBM) reported an otherwise solid quarter and Big Blue remains a respectable less-risk play on technology. 


A Mostly Solid First Quarter
IBM reported top-line growth of 8%, adjusted down to 5% on a constant currency basis. Growth was led by the Systems and Technology business (hardware, mostly), which posted 19% growth with strong mainframe and UNIX business. Software grew 6% this time around, while the services business rose by a like amount.

IBM also delivered solid operating leverage for the first quarter, though readers should realize that there are a lot of adjustments and moving parts here and the numbers will vary from investor to investor depending upon what charges they choose to add back. Nevertheless, gross margin ticked up almost a full point, while operating margin expanded nicely as adjusted operating profits grew more than 20%.


Continue on below:
http://stocks.investopedia.com/stock-analysis/2011/Signings-A-Small-Thorn-In-IBMs-Paw-IBM-INFY-CSC-DELL-EMC-CRM-RHT0425.aspx